<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101235741</journal-id>
<journal-id journal-id-type="pubmed-jr-id">32200</journal-id>
<journal-id journal-id-type="nlm-ta">Am J Med Genet A</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Med. Genet. A</journal-id>
<journal-title-group>
<journal-title>American journal of medical genetics. Part A</journal-title>
</journal-title-group>
<issn pub-type="ppub">1552-4825</issn>
<issn pub-type="epub">1552-4833</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29696780</article-id>
<article-id pub-id-type="pmc">6202262</article-id>
<article-id pub-id-type="doi">10.1002/ajmg.a.38709</article-id>
<article-id pub-id-type="manuscript">NIHMS970234</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Neurodevelopmental outcome in 22q11.2 deletion syndrome and management</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Swillen</surname>
<given-names>Ann</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN2">iD</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moss</surname>
<given-names>Edward</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Duijff</surname>
<given-names>Sasja</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Human Genetics, KU Leuven, Leuven, Belgium</aff>
<aff id="A2">
<label>2</label>Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania</aff>
<aff id="A3">
<label>3</label>University Medical Centre Utrecht, Utrecht, The Netherlands</aff>
<author-notes>
<corresp id="FN1"><bold>Correspondence</bold>. Ann Swillen, Department of Human Genetics, KU Leuven, Herestraat 49, Leuven 3000, Belgium, <email>ann.swillen@uzleuven.be</email>; <email>ann.swillen@kuleuven.be</email></corresp>
<fn id="FN2">
<p id="P1">
<bold>ORCID</bold>
</p>
<p id="P2"><italic>Ann Swillen</italic>
<ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0003-4258-4537">http://orcid.org/0000-0003-4258-4537</ext-link></p>
</fn>
<fn fn-type="COI-statement" id="FN3">
<p id="P30">
<bold>CONFLICT OF INTEREST</bold>
</p>
<p id="P31">None.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>24</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>25</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>31</day>
<month>10</month>
<year>2018</year>
</pub-date>
<volume>176</volume>
<issue>10</issue>
<fpage>2160</fpage>
<lpage>2166</lpage>
<!--elocation-id from pubmed: 10.1002/ajmg.a.38709-->
<abstract>
<p id="P3">The 22q11.2 deletion syndrome (22q11.2 DS) places affected individuals at an increased risk for neurodevelopmental/cognitive, behavioral and social–emotional difficulties. Poor cognitive functioning and intellectual disabilities, attention and executive functioning deficits, learning disorders, emotional dysregulation and impairments in social processing are common among individuals with 22q11.2 DS. Identifying risk and protective/resilience factors that can be detected in early life and can predict neurodevelopmental outcomes for people with 22q11.2 DS is of significant clinical relevance and might allow for early detection and intervention. Given the focus of this review, we will discuss the possible contributing factors that influence the neurodevelopmental outcome in 22q1.2 DS, the cognitive phenotype in 22q11.2 DS, the different developmental trajectories across life span, and the implications for clinical practice and management.</p>
</abstract>
<kwd-group>
<kwd>22q11.2 DS</kwd>
<kwd>contributing factors</kwd>
<kwd>neurodevelopmental outcome</kwd>
<kwd>practice and management</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>